Reviva Pharmaceuticals Holdings, Inc.
General ticker "RVPHW" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $34.0M (TTM average)
Reviva Pharmaceuticals Holdings, Inc. does not follow the US Stock Market performance with the rate: -14.0%.
Estimated limits based on current volatility of -0.7%: low 0.01$, high 0.01$
Factors to consider:
- Total employees count: 4 as of 2019
Short-term RVPHW quotes
Long-term RVPHW plot
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $24.31MM | $39.50MM | $30.80MM |
| Operating Income | $-24.31MM | $-39.50MM | $-30.80MM |
| Non-Operating Income | $-0.01MM | $0.26MM | $0.90MM |
| Interest Expense | $0.00MM | $0.00MM | $0.02MM |
| R&D Expense | $18.95MM | $31.42MM | $22.91MM |
| Income(Loss) | $-24.32MM | $-39.24MM | $-29.90MM |
| Taxes | $0.02MM | $0.02MM | $0.02MM |
| Profit(Loss)* | $-24.34MM | $-39.26MM | $-29.92MM |
| Stockholders Equity | $8.39MM | $5.72MM | $0.81MM |
| Assets | $18.92MM | $23.70MM | $15.50MM |
| Operating Cash Flow | $-18.96MM | $-28.32MM | $-33.54MM |
| Financing Cash Flow | $7.79MM | $33.17MM | $23.65MM |
| Earnings Per Share** | $-1.25 | $-1.65 | $-0.90 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.